Benefit of Sleep Quality Monitoring by EEG in ICU
ConditionRespiratory Failure
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Rouen
About this trial
The goal of this observational study is to learn about the benefit of monitoring sleep quality using EEG in patients hospitalized in critical care unit for acute respiratory failure. The main question it aims to answer is:
• Does EEG monitoring improve sleep quality assessment in critically ill patients with acute respiratory failure compared to nurse sleep quality assessment? Participants hospitalized in critical care unit for acute respiratory failure will have their sleep quality assessed by both EEG monitoring and nurse evaluation during their stay in critical care unit.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults
Acute respiratory failure with non-invasive ventilation or high-flow oxygenotherapy hospitalized in critical care unit
Conscious
Insurance coverage
Disqualifiers
pregnancy
cutaneous lesion on the scalp
guardianship
Trial population
During their stay in cricital care unit, patients with acute respiratory failure and ventilatory assistance by non-invasive ventilation and/or hig-flow oxygen therapy will included if all criteria are met. Participants will have their sleep quality assessed by both EEG monitoring and nurse assessment during the nights in critical care unit. Variables such as demographics, comorbidities, history of the disease leading to critical care unit, respiratory assessment, anxiety depression scale, sleep quality scale will be monitored.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
EEG monitoring
Other interventionParticipants will have their sleep quality assessed by both EEG monitoring and nurse evaluation during their stay in critical care unit.
Treatment groups
47 Participants
are divided into 1 treatment groupGroup A: Adults hospitalized in critical care for acute respiratory failure1 intervention
Trial outcomes
Primary outcomes
1
sleep stage
wake-sleep state mesured by both EEG montoring and nurse assessment
Time frame
through study completion, an average of 7 daysSecondary outcomes
1
total sleep time
measured by EEG monitoring
Time frame
periprocedurally2
sleep quality
mesured by richards-campbell sleep questionnaire
Time frame
through study completion, an average of 7 days3
anxiety
measured by HAD
Time frame
through study completion, an average of 7 days4
respiratory assessment
arterial blod gases
Time frame
through study completion, an average of 7 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov